Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Clindamycin palmitate hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for clindamycin palmitate hydrochloride and what is the scope of clindamycin palmitate hydrochloride patent protection?

Clindamycin palmitate hydrochloride
is the generic ingredient in two branded drugs marketed by Paddock Llc, Aurobindo Pharma Ltd, Amneal Pharms, Lyne, Pharmacia And Upjohn, Invagen Pharms, and Mylan Pharms Inc, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifty-two drug master file entries for clindamycin palmitate hydrochloride. Ten suppliers are listed for this compound.

Summary for Generic Name: clindamycin palmitate hydrochloride

Drug Master File Entries: see list52
Suppliers / Packagers: see list10
Bulk Api Vendors: see list26
Clinical Trials: see list1,061
Patent Applications: see list523
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:clindamycin palmitate hydrochloride at DailyMed

Pharmacology for Ingredient: clindamycin palmitate hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms
clindamycin palmitate hydrochloride
FOR SOLUTION;ORAL203513-001Mar 13, 2014AARXNoNo► Subscribe► Subscribe
Invagen Pharms
clindamycin palmitate hydrochloride
FOR SOLUTION;ORAL206958-001May 5, 2017AARXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
clindamycin palmitate hydrochloride
FOR SOLUTION;ORAL202409-001Apr 30, 2013AARXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
clindamycin palmitate hydrochloride
FOR SOLUTION;ORAL203063-001May 25, 2016AARXNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
clindamycin palmitate hydrochloride
FOR SOLUTION;ORAL061827-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus